Patents Assigned to Jenrm Discovery, Inc.
  • Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
    Patent number: 7759335
    Abstract: The present invention provides novel substituted amino-azetidines that are useful as cannabinoid receptor antagonists/inverse agonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, dyslipidemias, cardiovascular disorders, hepatic disorders, and a combination thereof.
    Type: Grant
    Filed: January 29, 2009
    Date of Patent: July 20, 2010
    Assignee: Jenrm Discovery, Inc.
    Inventors: John F. McElroy, Robert J. Chorvat